Translocations Flashcards

1
Q

AML M2 (myeloblastic with differentiation)

A

t(8;21) - good prognosis

AML1 gene on ch 21

ETO gene on 8q22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AML M3 (promyelocytic)

A

t(15;17)

PML gene on 15

RARA-alpha gene on 17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ML M4 (myelomonocytic with eosinophilia)

A

inv (16)(p13q22)

MYH11 and CBFb genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AML M5 (monoblastic)

A

t(9;11)

Abl1 gene on 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CML

A

t(9;22)

Abl1 gene on 9 fuses to BCR (“breakpoint cluster region”) on ch 22

reciprocal translocation

BCR-abl fusion protein - tyrosine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ALL

A

t(4;11)

AF4 on 4

MLL on 11q23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Burkitt’s

A

t(8;14)

t(2;8)

t(8;22)

C-MYC on 8q24

IgH on 14q32

kappa on 2

lambda on 22

** caveat: some cases of Burkitt lack these translocations and some cases of DLBCL have a myc translocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

follicular lymphoma

A

t(14;18)

IgH on 14q32

BCL-2 on 18q21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

B-lymphoblastic lymphoma

A

Good prognosis

  • t(12;21)(p13;q22); TEL/AML1
  • hyperdiploid > 50
  • age 4-10

Bad prognosis

  • t(9;22) (q34;q11.2); BCR/ABL
  • 11q23; MLL
  • t(1;19) (q23;p13.3); PBX/E2A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Marginal zone lymphoma

A

t(11;18)

API on 11

MLT-1 on 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bladder cancer

A

aneuploidy of chromosomes 3, 7, 17 and loss of 9p21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ewings sarcoma

A
  • t(11;22); EWS/FLI-1
  • t(21;22); EWS/ERG
  • many others; EWS/other
  • EWSR* gene on 22q12
  • FLI-1* gene on ch 11
  • ERG* gene on ch 21
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DSRCT

A

t(11;22); EWS/WT-1

WT-1 gene (Wilms tumor protein) on ch11

trilineage IHC markers: CK/EMA, desmin/vimentin, NSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clear cell sarcoma

A

t(12;22); EWS/ATF-1, EWS/TEC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Myxoid/round cell liposarcoma

A

t(12;16); FUS/CHOP

  • FUS* on 16p11
  • CHOP (DDIT3)* on 12q13

Myxoid/round cell liposarcoma is the second most common type of liposarcoma. Predictors of an unfavorable outcome include greater than 5% round cell component (i.e. high grade), necrosis and p53 overexpression. Mitotic rate, fusion transcript and mature adipocytic differentiation are not as good at predicting an unfavorable outcome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

alveolar soft part sarcoma

A

t(X;17) unbalanced translocation

ASPL/TFE3

sensitive and specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Synovial sarcoma

A

t(X;18); SYT/SSX1, SYT;SSX2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alveolar Rhabdomyosarcoma

A

t(1;13); PAX7/FKRH

t(2;13); PAX3/FKRH

FKRH = FOXO1 = Forkhead box proteoin O1 = Forkhead in rhabdomyosarcoma; located on chromosome 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DFSP

A

t(17;22); CALIA1/PDGF-BETA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Low grade fibromyxoid sarcoma

A

t(7;16); FUS/CREB

FUS = Fused in Sarcoma gene; on chromosome 16

**MUC4 is a new sensitive and specific marker for LGFMS vs other similar appearing soft tissue tumors!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

t(9;22)(q34;q11)

A

CML or ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

t(1;19)(q23;p13)

A

ALL

23
Q

t(8;14)(q24;q11)

A

Burkitt lymphoma

24
Q

t(8;21)(q22;q22)

A

AML M2

25
Q

Embryonal rhabdomyosarcoma

A

LOH 11p15.5

(embryonal has better px than aleolar RMS)

26
Q

embryonal rhabdomyosarcoma

A

LOH 11p15.5

27
Q

infantile fibrosarcoma and congenital mesoblastic nephroma

A

t(12;15)

28
Q

AML translocations associated with a good prognosis

A

t(15;17)

t(8;21)

Inv16

29
Q

most common translocation seen in childhood B-ALL

A

t(12;21) –> TEL/AML1

Good prognosis!

30
Q

cytogenetics associated with GOOD prognosis in ALL

A

t(12;21) –> TEL:AML1 fusion (need molecular b/c karyotype may miss)

Hyperdiploidy (>50 chromosomes)

del(9q) –> good in adults; not so good in kids

31
Q

cytogenetics associated with BAD prognosis in ALL

A

t(9:22)

t(1;19) - no longer poor px with appropriate therapy

t(4;11) - neonatal acute mixed lineage leukemia

t(8;14) - uncommon in true ALL

hypodiploidy

complex karyotype (5 or more abnormalities)

32
Q

round cell liposarcoma

A

t(12;22)

DDIT3(CHOP) on ch 12

EWS on ch22

33
Q

well-diff/de-diff liposarcoma

A

Ring or giant marker/rod chromosomes derived from 12q13-15 in almost all cases

MDM2 amplification in well-differentiated liposarcoma

34
Q

trisomies 8 & 20

A

desmoiods

embryonal rhabdo

infantile fibrosarcome

35
Q

extraskeletal myxoid chrondrosarcoma

A

t(9;22)(q22-31;q11-12) EWS–CHN

or

t(9;17)(q22;q11) RBP56–CHN

36
Q

papillary renal cell carcinoma

A

+7, +17, -Y

37
Q

pediatric papillary renal cell carcinoma (translocation carcinoma)

A

TFE3 transcription factor gene (Xp11.2)

(t(X;17)(p11.2;q25) - balanced translocation of TFE3 gene at Xp11.2 and ASPL gene at 17q25; also found in alveolar soft part sarcoma, but unbalanced)

or

TFEB protein (11q12)


38
Q

medullary carcinoma (kidney)

A

monosomy 11 (loss of INI-1)

39
Q

Wilms tumor (nephroblastoma)

A
  1. ** WAGR** (Wilms, Aniridia, Genital anomalies, mental Retardation) - 11p13 aniridia gene + WT-1 gene deletion
  2. Denys-Drash syndrome (gonadal dysgenesis & nephropathy) - 11p13 mutation that affects DNA binding to WT-1
  3. Beckwith-Wiedemann syndrome (enlargement of orgna, hemihypertrophy, renal medullary cysts, adrenal cytomegaly) - 11p15.5, distal to WT-1 - possible genetic imprinting at WT-2
40
Q

Rhabdoid tumor

A

Deletions or mutations of hSNF5 / INI1 / SMARCB1 gene at 22q11.2, which is associated with loss of INI1 nuclear staining
● Note: this alternation is also seen in renal medullary carcinoma (Mod Pathol 2008;21:647) and epithelioid sarcoma

t(11;22) - different from Ewing/PNET

41
Q

mesoblastic nephroma

A

t(12;15) ETVt-NTRK3

* same as infantile fibrosarcoma

42
Q

Hepatoblastoma

A

LOH 11p

assoc with Beckwith-Wiedeman and FAP

43
Q

chondroid lipoma

A

t(11;16)(q13;p13)

MKL2-C11orf95 fusion gene

44
Q

angiosarcoma secondary to radiation

A

8q24 chromosomal gains (MYC amplification) - found in 100% of secondary angiosarcoma but in primary angiosarcoma or in radiation-associated atypical vascular lesions or other radiation-associated sarcomas

45
Q

angiomatoid fibrous histiocytoma

A

EWSR1-CREB1

46
Q

lipoma

A

frequently (2/3) have 12q13-15 abnormalities

47
Q

spindle cell lipoma

A

abnormalities of 13q14-22

decreases RB protein expression

male:female=9:1

most occur in the lower neck/upper back region

48
Q

aneurysmal bone cyst

A

t(16;17) resulting in CDH11:USP6 fusion

49
Q

Secretory breast carcinoma

A

t(12;15)

ETV6-NTRK3

abundant intra- and extracellular PAS-positive, diastase-resistant secretions

Despite its typical “triple negative” phenotype, in general secretory carcinoma has a favorable prognosis.

50
Q

independent prognostic indicator in node negative breast cancer

A

S phase fraction

tumor size

tumor grade

cathepsin-D (a lysosomal acidic protease that can react against basement membranes and may play a role in tumor growth and metastatic potential)

Ki-67

mitotic index

vascular invasion

51
Q

poor prognostic indicator in neuroblasoma

A
52
Q

adenoid cystic carcinoma

A

t(6;9)(q22-23;p23-24)

MYB-NFIB fusion protein

53
Q

mucoepidermoid carcinoma

A

t(11;19)(q14-21;p12-13)